Drugs Health Pharma

AstraZeneca, Daiichi’s breast cancer drug trials show rise in survival

HQ Team June 3, 2024: An antibody-drug conjugate, jointly being developed by AstraZeneca and Daiichi Sankyo, has been shown in end-stage clinical trials.

Read More
Drugs Health Pharma

Global pandemic accord may see the light of day in 2025, ‘or earlier’: WHO

Negotiations at reaching a global accord to help fight pandemics better will conclude by 2025 or “earlier if possible at a special session.

Read More
Drugs Health Pharma

Pfizer’s drug helps people with rare lung cancer live longer, data shows

Sixty percent of the patients treated with Pfizer’s Lorbrena drug, for a rare form of advanced lung cancer, were alive without disease progression.

Read More
Drugs Health Pharma

Hunger, famine, stare at displaced Sudanese, WHO appeals for funds 

Eighteen million people are “acutely” hungry in conflict-ridden Sudan as a famine is on the horizon and 800,000 civilians get ready for large-scale.

Read More
Health Medical Pharma

Medical education in the UK inflicting ‘pervasive harm’ on students: Expert

Technology-based medical training has led to junior doctors avoiding the ward to stick to the electronic tablet — a healthcare crisis that will.

Read More
Drugs Health Pharma

Biogen’s ALS drug gets European Commission’s marketing nod

The European Commission has granted marketing approval for Biogen Inc.’s therapy for the treatment of a form of amyotrophic lateral sclerosis.

Read More
Drugs Health Pharma

US reports a third human case of highly pathogenic avian influenza

A dairy farm worker in Michigan, US, has been infected with highly pathogenic avian influenza from sick cows —the third such case in America.

Read More
Drugs Health Pharma

J & J to buy rights for experimental skin disorder drug for $1.25 billion

Johnson & Johnson has agreed to buy the rights for an investigational skin disorder treatment from Numab Therapeutics for $1.25 billion.

Read More
Drugs Health Pharma

US drug regulator clears Amgen’s biosimilar to treat rare blood disorder

The US drug regulator has approved Amen’s biosimilar, Bkemv,  to treat rare blood disorders, according to a statement from the Food and Drug.

Read More
Drugs Health Pharma

Air pollution triggering heart diseases across the globe: WHF report

About 70% of the 4.2 million deaths in 2019 attributed to air pollution were caused by cardiovascular conditions — ischaemic heart disease and.

Read More